Biospecimen Repository for Interstitial Lung Diseases
common.study.values.description
“Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)”
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
ILD
100 cc of blood collected from a total of 250 ILD patients. This includes IPF (n=100), fibrotic NSIP (n=50), chronic hypersensitivity pneumonia (n=20), sarcoidosis(n=50), progressive rheumatoid lung disease (n=10) and scleroderma lung disease (n=20)), 10 patients with other fibrosing disease (fibrosing mediastinitis), and 50 patients with lymphangioleiomyomatosis
Healthy
100 cc of blood collected from a total of 25 healthy volunteers in order to compare with the ILD participants.
Pneumonia
100 cc of blood collected from a total of 100 participants with a diagnosis of pneumonia in order to compare with the ILD participants.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
common.study.values.clinical-trial-id
NCT03478826
participant.views.study.view.id
9aARjb
